Cargando…

Role of Natural Killer Cells in Innate Protection against Lethal Ebola Virus Infection

Ebola virus is a highly lethal human pathogen and is rapidly driving many wild primate populations toward extinction. Several lines of evidence suggest that innate, nonspecific host factors are potentially critical for survival after Ebola virus infection. Here, we show that nonreplicating Ebola vir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warfield, Kelly L., Perkins, Jeremy G., Swenson, Dana L., Deal, Emily M., Bosio, Catharine M., Aman, M. Javad, Yokoyama, Wayne M., Young, Howard A., Bavari, Sina
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2004
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212007/ https://www.ncbi.nlm.nih.gov/pubmed/15249592 http://dx.doi.org/10.1084/jem.20032141

Ejemplares similares

Homologous and Heterologous Protection of Nonhuman Primates by Ebola and Sudan Virus-Like Particles
por: Warfield, Kelly L., et al.
Publicado: (2015)

Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino Oligomers
por: Warfield, Kelly L, et al.
Publicado: (2006)

Lipid Raft Microdomains: A Gateway for Compartmentalized Trafficking of Ebola and Marburg Viruses
por: Bavari, Sina, et al.
Publicado: (2002)

Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges)
por: Dye, John M., et al.
Publicado: (2016)

Assembly of Ebola Virus Matrix Protein VP40 Is Regulated by Latch-Like Properties of N and C Terminal Tails
por: Silva, Leslie P., et al.
Publicado: (2012)

Treatment of highly pathogenic filovirus infections using advanced antisense technology
por: Warren, Travis, et al.
Publicado: (2010)

Discovering Drugs for the Treatment of Ebola Virus
por: Bixler, Sandra L., et al.
Publicado: (2017)

Chasing Ebola through the Endosomal Labyrinth
por: Aman, M. Javad
Publicado: (2016)

A Single Phosphorodiamidate Morpholino Oligomer Targeting VP24 Protects Rhesus Monkeys against Lethal Ebola Virus Infection
por: Warren, Travis K., et al.
Publicado: (2015)

Ebola, the killer virus
por: Ghazanfar, Haider, et al.
Publicado: (2015)

Discovery of common marburgvirus protective epitopes in a BALB/c mouse model
por: Kalina, Warren V, et al.
Publicado: (2009)

Oligonucleotide antiviral therapeutics: Antisense and RNA interference for highly pathogenic RNA viruses
por: Spurgers, Kevin B., et al.
Publicado: (2008)

Ebola: Profile of a Killer Virus
por: Morse, Stephen S.
Publicado: (2017)

T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection
por: Cooper, Christopher L, et al.
Publicado: (2017)

The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells
por: Edri, Avishay, et al.
Publicado: (2018)

Natural killer cells and autoimmunity
por: French, Anthony R, et al.
Publicado: (2004)

A thermostable, chromatographically purified Ebola nano-VLP vaccine
por: Carra, John H, et al.
Publicado: (2015)

Mechanisms of Immunity in Post-Exposure Vaccination against Ebola Virus Infection
por: Bradfute, Steven B., et al.
Publicado: (2015)

Reidentification of Ebola Virus E718 and ME as Ebola Virus/H.sapiens-tc/COD/1976/Yambuku-Ecran
por: Kuhn, Jens H., et al.
Publicado: (2014)

In Vivo and In Vitro Characterization of Provodine, a Long Acting, Alcohol-Free Professional Antiseptic, Against Ebola Virus and Other Serious Viral, Bacterial and Fungal Pathogens
por: Lentini, Peter, et al.
Publicado: (2015)

Identification of RUVBL1 and RUVBL2 as Novel Cellular Interactors of the Ebola Virus Nucleoprotein
por: Morwitzer, M. Jane, et al.
Publicado: (2019)

Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection
por: Qiu, Xiangguo, et al.
Publicado: (2012)

Uterine Natural Killer Cells
por: Sojka, Dorothy K., et al.
Publicado: (2019)

Virus-Like Particles Activate Type I Interferon Pathways to Facilitate Post-Exposure Protection against Ebola Virus Infection
por: Ayithan, Natarajan, et al.
Publicado: (2015)

Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge
por: Konduru, Krishnamurthy, et al.
Publicado: (2016)

Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion
por: Pleet, Michelle L., et al.
Publicado: (2019)

Discovery and Early Development of AVI-7537 and AVI-7288 for the Treatment of Ebola Virus and Marburg Virus Infections
por: Iversen, Patrick L., et al.
Publicado: (2012)

Antibody-Dependent Natural Killer Cell Activation After Ebola Vaccination
por: Wagstaffe, Helen R, et al.
Publicado: (2019)

Histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model
por: Cooper, Timothy K., et al.
Publicado: (2018)

Contribution of natural killer cells in innate immunity against colorectal cancer
por: Ghazvinian, Zeinab, et al.
Publicado: (2023)

Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model
por: Miller, Joanna L., et al.
Publicado: (2016)

Natural killer cells in human autoimmune disorders
por: Fogel, Leslie A, et al.
Publicado: (2013)

Biochip for the Detection of Bacillus anthracis Lethal Factor and Therapeutic Agents against Anthrax Toxins
por: Silin, Vitalii, et al.
Publicado: (2016)

Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus
por: Warren, Travis K., et al.
Publicado: (2021)

Ebola Virus Causes Intestinal Tract Architectural Disruption and Bacterial Invasion in Non-Human Primates
por: Reisler, Ronald B., et al.
Publicado: (2018)

High Content Image Based Analysis Identifies Cell Cycle Inhibitors as Regulators of Ebola Virus Infection
por: Kota, Krishna P., et al.
Publicado: (2012)

Author Correction: Histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model
por: Cooper, Timothy K., et al.
Publicado: (2019)

Inhibition of Ebola Virus Entry by a C-peptide Targeted to Endosomes
por: Miller, Emily Happy, et al.
Publicado: (2011)

Ebola virus shed glycoprotein is toxic to human T, B, and natural killer lymphocytes
por: Perez-Valencia, Luis J., et al.
Publicado: (2023)

Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge
por: Marzi, Andrea, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5bqv94v7mljkvspqncju751lqf